{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T19:48:06Z","timestamp":1766087286939},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2018,4,7]],"date-time":"2018-04-07T00:00:00Z","timestamp":1523059200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,7,1]]},"DOI":"10.1093\/chromsci\/bmy024","type":"journal-article","created":{"date-parts":[[2018,3,16]],"date-time":"2018-03-16T16:06:05Z","timestamp":1521216365000},"page":"510-517","source":"Crossref","is-referenced-by-count":34,"title":["Simultaneous Determination of Antipsychotic Drugs and Their Active Metabolites by LC\u2013MS-MS and its Application to Therapeutic Drug Monitoring"],"prefix":"10.1093","volume":"56","author":[{"given":"Igor I","family":"Miroshnichenko","sequence":"first","affiliation":[{"name":"Mental Health Research Center, Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia V","family":"Baymeeva","sequence":"additional","affiliation":[{"name":"Mental Health Research Center, Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,4,7]]},"reference":[{"key":"key\n\t\t\t\t20180612082753_bmy024C1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00228-013-1504-x","article-title":"Therapeutic drug monitoring for tomorrow","volume":"69","author":"Eliasson","year":"2013","journal-title":"European Journal of Clinical Pharmacology"},{"key":"key\n\t\t\t\t20180612082753_bmy024C2","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1177\/2045125315588032","article-title":"Antipsychotic therapeutic drug monitoring: psychiatrists\u2019 attitudes and factors predicting likely future use","volume":"5","author":"Law","year":"2015","journal-title":"Therapeutic Advances in Psychopharmacology"},{"key":"key\n\t\t\t\t20180612082753_bmy024C3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2478\/acph-2014-0036","article-title":"Therapeutic drug monitoring of atypical antipsychotic drugs","volume":"64","author":"Grundmann","year":"2014","journal-title":"Acta Pharmaceutica"},{"key":"key\n\t\t\t\t20180612082753_bmy024C4","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s11094-016-1448-4","article-title":"Analytical methods for the determination of atypical neuroleptics","volume":"50","author":"Baimeeva","year":"2016","journal-title":"Pharmaceutical Chemistry Journal"},{"key":"key\n\t\t\t\t20180612082753_bmy024C5","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1373\/clinchem.2011.167189","article-title":"Liquid chromatography-tandem mass spectrometry or automated immunoassays: what are the future trends in therapeutic drug monitoring?","volume":"58","author":"Brandhorst","year":"2012","journal-title":"Clinical Chemistry"},{"key":"key\n\t\t\t\t20180612082753_bmy024C6","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jchromb.2016.10.031","article-title":"Determination of antipsychotic drugs in hospital and waste water treatment plant samples by gas chromatography\/tandem mass spectrometry","volume":"1038","author":"Logarinho","year":"2016","journal-title":"Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences"},{"key":"key\n\t\t\t\t20180612082753_bmy024C7","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ab.2008.11.027","article-title":"Development of an LC-MS\/MS method for the simultaneous quantification of aripiprazole and dehydroaripiprazole in human serum","volume":"385","author":"Song","year":"2009","journal-title":"Analytical Biochemistry"},{"key":"key\n\t\t\t\t20180612082753_bmy024C8","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/jat\/33.4.198","article-title":"Therapeutic drug monitoring of clozapine and norclozapine in human serum using ultra-performance liquid chromatography-tandem mass spectrometry","volume":"33","author":"Ming","year":"2009","journal-title":"Journal of Analytical Toxicology"},{"key":"key\n\t\t\t\t20180612082753_bmy024C9","first-page":"32","article-title":"Quantitative determination of aripiprazole, risperidone and their active metabolites in human serum by high-performance liquid chromatographic\u2013tandem mass spectrometric in human serum","volume":"3","author":"Baymeeva","year":"2014","journal-title":"Drug Development & Registration"},{"key":"key\n\t\t\t\t20180612082753_bmy024C10","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s11094-013-0934-1","article-title":"Quantitative determination of anastrozole by LC\u2013MS-MS","volume":"47","author":"Miroshnichenko","year":"2013","journal-title":"Chemical Pharmaceutical Journal"},{"key":"key\n\t\t\t\t20180612082753_bmy024C11","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jpba.2013.02.017","article-title":"Development of a validated LC-MS\/MS method for determination of doxofylline on rat dried bloodspots and urine: application to pharmacokinetics","volume":"78\u201379","author":"Rao","year":"2013","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"key":"key\n\t\t\t\t20180612082753_bmy024C12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jchromb.2013.09.014","article-title":"Enantioselective determination of 3-n-butylphthalide (NBP) in human plasma by liquid chromatography on a teicoplanin-based chiral column coupled with tandem mass spectrometry","volume":"939","author":"Diao","year":"2013","journal-title":"Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences"},{"key":"key\n\t\t\t\t20180612082753_bmy024C13","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.4155\/bio-2017-0214","article-title":"Matrix effects and application of matrix effect factor","volume":"23","author":"Zhou","year":"2017","journal-title":"Bioanalysis"},{"key":"key\n\t\t\t\t20180612082753_bmy024C14","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC\u2010MS\/MS","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Analytical Chemistry"},{"key":"key\n\t\t\t\t20180612082753_bmy024C15","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1248\/yakushi.130.1325","article-title":"Pharmacologically active metabolites of currently marketed drugs: potential resources for new drug discovery and development","volume":"130","author":"Kang","year":"2010","journal-title":"Yakugaku Zasshi"},{"key":"key\n\t\t\t\t20180612082753_bmy024C16","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.mehy.2012.12.024","article-title":"Increasing the clozapine: norclozapine ratio with co-administration of fluvoxamine to enhance efficacy and minimize side effects of clozapine therapy","volume":"80","author":"Legare","year":"2013","journal-title":"Medical Hypotheses"},{"key":"key\n\t\t\t\t20180612082753_bmy024C17","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1365-2125.2011.04071.x","article-title":"Applications of stable isotopes in clinical pharmacology","volume":"72","author":"Schellekens","year":"2011","journal-title":"British Journal of Clinical Pharmacology"},{"key":"key\n\t\t\t\t20180612082753_bmy024C18","doi-asserted-by":"crossref","first-page":"607","DOI":"10.4155\/bio.16.21","article-title":"Should commonly prescribed drugs be avoided as internal standard choices in new assays for clinical samples?","volume":"8","author":"Srinivas","year":"2016","journal-title":"Bioanalysis"},{"key":"key\n\t\t\t\t20180612082753_bmy024C19","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jchromb.2010.11.024","article-title":"Quantification of antidepressants and antipsychotics in human serum by precipitation and ultra high pressure liquid chromatography\u2013tandem mass spectrometry","volume":"879","author":"Hasselstrom","year":"2011","journal-title":"Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences"},{"key":"key\n\t\t\t\t20180612082753_bmy024C20","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/bmc.1750","article-title":"Development of a rapid and sensitive SPE-LC\u2013MS\/MS method for the simultaneous estimation of fluoxetine and olanzapine in human plasma","volume":"26","author":"Gopinath","year":"2012","journal-title":"Biomedical Chromatography"},{"key":"key\n\t\t\t\t20180612082753_bmy024C21","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.jpba.2009.07.007","article-title":"Therapeutic drug monitoring of seven psychotropic drugs and four metabolites in human plasma by HPLC\u2013MS","volume":"50","author":"Choonga","year":"2009","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"}],"container-title":["Journal of Chromatographic Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/chromsci\/article-pdf\/56\/6\/510\/25036291\/bmy024.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,12]],"date-time":"2019-10-12T21:17:38Z","timestamp":1570915058000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/chromsci\/article\/56\/6\/510\/4964039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,7]]},"references-count":21,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,4,7]]},"published-print":{"date-parts":[[2018,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/chromsci\/bmy024","relation":{},"ISSN":["0021-9665","1945-239X"],"issn-type":[{"value":"0021-9665","type":"print"},{"value":"1945-239X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,7]]},"published":{"date-parts":[[2018,4,7]]}}}